Furthermore, p62 expression can modulate responsiveness to radiotherapy, chemotherapy, and immunotherapy, highlighting its importance in cancer therapy and resistance mechanisms [7, 35, 70, 110]. This evidence concerns the gene SQSTM1 and cancer.